Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 11, 1997, Pages 846-848

  Nguyen, M H ^a,b   Clancy, C J ^a   Yu, Y C ^a   Lewin, A S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AZITHROMYCIN; BACTERIAL PROTEIN; METHIONINE; SULFUR 35;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ISOTOPE LABELING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT;

EID: 0030697938     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01700417     Document Type: Article

References (15)

1. Kitahara M, Seth VK, Medoff G, Kabayashi GS: Antimicrobial susceptibility testing of six clinical isolates of Aspergillus. Antimicrobial Agents and Chemotherapy 1976, 9: 908-914.
2. Kwan CN, Medoff G, Kobayashi GS, Schlessinger D, Raskas HJ: Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrobial Agents and Chemotherapy 1972, 2: 61-65.
3. Lew MA, Beckett KM, Levin MJ: Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. Journal of Infectious Diseases 1977, 136: 263-270.
4. Andersen SL, Ager A, McGreevy P, Schuster BG, Wesche D, Kuschner R, Ohrt C, Ellis W, Rossan R, Berman J: Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. American Journal of Tropical Medical Hygiene 1995, 52: 159-161.
5. Beckers CJ, Roos DS, Donald RG, Luft BJ, Schwab JC, Cao Y, Joiner KA: Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii: implications for the target of macrolide antibiotics. Journal of Clinical Investigation 1995, 95: 367-376.
6. Karma P, Pukander J, Penttila M: Azithromycin concentrations in sinus fluid and mucosa after oral administration. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 856-859.
7. Schentag JJ, Ballow CH: Tissue-directed pharmacokinetics. American Journal of Medicine 1991, 91: 5-11.
8. Wildfeuer A, Laufen H, Zimmermann T: Distribution of orally administered azithromycin in various blood compartments. International Journal of Clinical Pharmacology and Therapeutics 1994, 32: 356-360.
9. Cooper MA, Nye V, Andrews JM, Wise R: The pharmacokinetics of inflammatory fluid penetration of orally administered azithromycin. Journal of Antimicrobial Chemotherapy 1990, 26: 533-538.
10. Retsema JA, Bergeron JM, Girard D, Milisen WB, Girard AE: Preferential concentration of azithromycin in an infected mouse thigh model. Journal of Antimicrobial Chemotherapy 1993, 31: 5-16.
11. Nguyen MH, Barchiesi F, McGough DA, Yu VL, Rinaldi MG: In vitro evaluation of combination of fluconazole and flucytoslne against Cryptococcus neoformans var. neoformans. Antimicrobial Agents and Chemotherapy 1995, 39: 1691-1695.
12. Espinell-Ingroff A, Dawson K, Pfaller M, Anaissie E, Breslin B, Dixon D, Fothergill A, Paetznick V, Peter J, Rinaldi M, Walsh T: Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 1995, 39: 314-319.
13. Fleischer S, Packer L: Bioenergetics: Biogenesis of mitochondria, organization, and transport. In: Colowick SP, Kaplan NO (ed): Methods in enzymology. Volume LVI. Academic Press, New York, 1979, p. 23.
14. Kazuhiro T, Ishii Y, Matsumoto T, Ohno A, Yamaguchi K: Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrobial Agents and Chemotherapy 1996, 40: 2271-2275.
15. Linnane AW, Lamb AJ, Christodoulou C, Lukins HB: The biogenesis of mitochondria, VI. Biochemical basis of the resistance of Saccharomyces cerevisiae toward antibiotics which specifically inhibit mitochondrial protein synthesis. Proceedings of the National Academy of Sciences of the USA 1968, 59: 1288-1293.